(Q35798817)

10 August 2017

1 reference

title

Approximate equivalent rosuvastatin doses for temporary statin interchange programs (English)

1 reference

10 August 2017

Michael G Kendrach

1

1 reference

10 August 2017

Maisha Kelly-Freeman

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

8 June 2004

1 reference

Annals of Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

38

1 reference

10 August 2017

issue

7-8

1 reference

10 August 2017

page(s)

1286-1292

1 reference

Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease

10 August 2017

cites work

1 reference

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

21 January 2018

1 reference

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

21 January 2018

1 reference

Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia

21 January 2018

1 reference

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial

21 January 2018

1 reference

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

21 January 2018

1 reference

Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

21 January 2018

1 reference

Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.

21 January 2018

1 reference

Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D391

1 reference

10 August 2017

1 reference